IDO-1 activity is a compelling target biomarker for TB diagnostics due to multiple studies demonstrating changes in this pathway in a variety of types of TB, as well as the availability of an inhibitor, 1-methyl-tryptophan, that has been associated with clinical improvement and increased Mtb killing (18). Here, IDO1 is linked to tuberculosis.